Tapewire

Nasdaq · USD

IRWD

IRONWOOD PHARMACEUTICALS INC

Export transactions ↓
Tapewire entity
5213
SEC CIK
0001446847
Parsed reports
478

Last 12 months

Inside the activity.

0 purchase rows · 18 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202601
Feb 2026012
Mar 202602
Apr 202600
May 202600
Jun 202601
Jul 202601
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 27, 2023 Filed Mar 29, 2023 16:05 UTC
MCCOURT Thomas ADirector · Chief Executive Officer
SaleClass A Common Stock 46,129 $10.67 $492,196.43
Disclosure

SEC source: 0001209191-23-021524 · doc4.xml · nonDerivative · entry 1

MCCOURT Thomas A · CIK 0001478448 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 842,064

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.58 to $10.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
March 15, 2023 Filed Mar 17, 2023 20:05 UTC GrantClass A Common Stock 1,677 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-019597 · doc4.xml · nonDerivative · entry 1

Moukheibir Catherine · CIK 0001772130 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,027

F1 · kind: Issued pursuant to the Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2023.

Read SEC document
March 15, 2023 Filed Mar 17, 2023 20:05 UTC
DENNER ALEXANDER JDirector · 10% owner
GrantClass A Common Stock 1,438 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-019596 · doc4.xml · nonDerivative · entry 1

DENNER ALEXANDER J · CIK 0001361754 · Director · 10% owner

Sarissa Capital Management LP · CIK 0001577524 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,423

F1 · kind: Issued pursuant to the Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2023.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 17:13 UTC
Shetzline MichaelCMO,SVP,Head-Res&Drug
GrantPerformance-based Restricted Stock Units · Derivative 34,935 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017889 · doc4.xml · derivative · entry 2

Shetzline Michael · CIK 0001808509 · CMO,SVP,Head-Res&Drug

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,935

Underlying: Class A Common Stock · 34,935 shares

Expires 2026-02-28

F2 · derivative.exercise_price: Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share.

F2 · derivative.exercise_date: Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 17:13 UTC
Shetzline MichaelCMO,SVP,Head-Res&Drug
GrantClass A Common Stock 69,869 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017889 · doc4.xml · nonDerivative · entry 1

Shetzline Michael · CIK 0001808509 · CMO,SVP,Head-Res&Drug

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 331,455

F1 · kind: The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 17:10 UTC
John MinardoChief Legal Officer
GrantPerformance-based Restricted Stock Units · Derivative 32,751 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017883 · doc4.xml · derivative · entry 2

John Minardo · CIK 0001875067 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,751

Underlying: Class A Common Stock · 32,751 shares

Expires 2026-02-28

F2 · derivative.exercise_price: Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share.

F2 · derivative.exercise_date: Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 17:10 UTC
John MinardoChief Legal Officer
GrantClass A Common Stock 65,502 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017883 · doc4.xml · nonDerivative · entry 1

John Minardo · CIK 0001875067 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 199,240

F1 · kind: The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 17:12 UTC
Rickard JasonSVP, Chief Operating Officer
GrantPerformance-based Restricted Stock Units · Derivative 21,834 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017886 · doc4.xml · derivative · entry 2

Rickard Jason · CIK 0001808505 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,834

Underlying: Class A Common Stock · 21,834 shares

Expires 2026-02-28

F2 · derivative.exercise_price: Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share.

F2 · derivative.exercise_date: Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 17:12 UTC
Rickard JasonSVP, Chief Operating Officer
GrantClass A Common Stock 43,668 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017886 · doc4.xml · nonDerivative · entry 1

Rickard Jason · CIK 0001808505 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 376,316

F1 · kind: The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 17:09 UTC
MCCOURT Thomas ADirector · Chief Executive Officer
GrantPerformance-based Restricted Stock Units · Derivative 120,297 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017882 · doc4.xml · derivative · entry 2

MCCOURT Thomas A · CIK 0001478448 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,297

Underlying: Class A Common Stock · 120,297 shares

Expires 2026-02-28

F2 · derivative.exercise_price: Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share.

F2 · derivative.exercise_date: Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 17:09 UTC
MCCOURT Thomas ADirector · Chief Executive Officer
GrantClass A Common Stock 240,595 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017882 · doc4.xml · nonDerivative · entry 1

MCCOURT Thomas A · CIK 0001478448 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 888,193

F1 · kind: The restricted stock unit award, granted as an annual performance award, vests as to 33.33% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 22:15 UTC
Silver RonaldPrincipal Accounting Officer
GrantClass A Common Stock 35,620 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017892 · doc4.xml · nonDerivative · entry 1

Silver Ronald · CIK 0001873731 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,111

F1 · kind: The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 22:08 UTC
Emany Sravan KumarSVP, Chief Financial Officer
GrantPerformance-based Restricted Stock Units · Derivative 37,118 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017878 · doc4.xml · derivative · entry 2

Emany Sravan Kumar · CIK 0001897662 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,118

Underlying: Class A Common Stock · 37,118 shares

Expires 2026-02-28

F2 · derivative.exercise_price: Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share.

F2 · derivative.exercise_date: Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 22:08 UTC
Emany Sravan KumarSVP, Chief Financial Officer
GrantClass A Common Stock 74,236 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017878 · doc4.xml · nonDerivative · entry 1

Emany Sravan Kumar · CIK 0001897662 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,658

F1 · kind: The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 22:07 UTC
Davis AndrewSVP, Chief Business Officer
GrantPerformance-based Restricted Stock Units · Derivative 37,118 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017873 · doc4.xml · derivative · entry 2

Davis Andrew · CIK 0001932525 · SVP, Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,118

Underlying: Class A Common Stock · 37,118 shares

Expires 2026-02-28

F2 · derivative.exercise_price: Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share.

F2 · derivative.exercise_date: Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 22:07 UTC
Davis AndrewSVP, Chief Business Officer
GrantClass A Common Stock 74,236 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017873 · doc4.xml · nonDerivative · entry 1

Davis Andrew · CIK 0001932525 · SVP, Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 225,632

F1 · kind: The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.

Read SEC document
March 03, 2023 Filed Mar 7, 2023 16:05 UTC
MCCOURT Thomas ADirector · Chief Executive Officer
SaleClass A Common Stock 33,756 $11.22 $378,742.32
Disclosure

SEC source: 0001209191-23-016696 · doc4.xml · nonDerivative · entry 1

MCCOURT Thomas A · CIK 0001478448 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 647,598

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.16 to $11.33, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
February 28, 2023 Filed Mar 1, 2023 18:21 UTC
Shetzline MichaelCMO,SVP,Head-Res&Drug
SaleClass A Common Stock 2,416 $11.31 $27,324.96
Disclosure

SEC source: 0001209191-23-014280 · doc4.xml · nonDerivative · entry 4

Shetzline Michael · CIK 0001808509 · CMO,SVP,Head-Res&Drug

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 261,586

F3 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based restricted stock units granted on February 27, 2020 and April 24, 2020. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.26 to $11.38, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
February 28, 2023 Filed Mar 1, 2023 18:21 UTC
Shetzline MichaelCMO,SVP,Head-Res&Drug
SaleClass A Common Stock 7,438 $11.31 $84,123.78
Disclosure

SEC source: 0001209191-23-014280 · doc4.xml · nonDerivative · entry 3

Shetzline Michael · CIK 0001808509 · CMO,SVP,Head-Res&Drug

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 264,002

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.26 to $11.38, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
February 28, 2023 Filed Mar 1, 2023 18:19 UTC
John MinardoChief Legal Officer
SaleClass A Common Stock 3,415 $11.31 $38,623.65
Disclosure

SEC source: 0001209191-23-014277 · doc4.xml · nonDerivative · entry 2

John Minardo · CIK 0001875067 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,738

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.26 to $11.38, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
February 28, 2023 Filed Mar 1, 2023 18:24 UTC
Rickard JasonSVP, Chief Operating Officer
SaleClass A Common Stock 3,442 $11.31 $38,929.02
Disclosure

SEC source: 0001209191-23-014285 · doc4.xml · nonDerivative · entry 4

Rickard Jason · CIK 0001808505 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 332,648

F3 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based restricted stock units granted on February 27, 2020. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.26 to $11.38, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
February 28, 2023 Filed Mar 1, 2023 18:24 UTC
Rickard JasonSVP, Chief Operating Officer
SaleClass A Common Stock 13,987 $11.31 $158,192.97
Disclosure

SEC source: 0001209191-23-014285 · doc4.xml · nonDerivative · entry 3

Rickard Jason · CIK 0001808505 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 336,090

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.26 to $11.38, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
February 28, 2023 Filed Mar 1, 2023 18:22 UTC
MCCOURT Thomas ADirector · Chief Executive Officer
SaleClass A Common Stock 4,588 $11.31 $51,890.28
Disclosure

SEC source: 0001209191-23-014283 · doc4.xml · nonDerivative · entry 4

MCCOURT Thomas A · CIK 0001478448 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 681,354

F3 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based restricted stock units granted on February 27, 2020. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.26 to $11.38, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
February 28, 2023 Filed Mar 1, 2023 18:22 UTC
MCCOURT Thomas ADirector · Chief Executive Officer
SaleClass A Common Stock 26,639 $11.31 $301,287.09
Disclosure

SEC source: 0001209191-23-014283 · doc4.xml · nonDerivative · entry 3

MCCOURT Thomas A · CIK 0001478448 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 685,942

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.26 to $11.38, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
February 28, 2023 Filed Mar 1, 2023 23:25 UTC
Silver RonaldPrincipal Accounting Officer
SaleClass A Common Stock 3,049 $11.31 $34,484.19
Disclosure

SEC source: 0001209191-23-014286 · doc4.xml · nonDerivative · entry 2

Silver Ronald · CIK 0001873731 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,491

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.26 to $11.38, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
February 28, 2023 Filed Mar 1, 2023 23:17 UTC
Davis AndrewSVP, Chief Business Officer
SaleClass A Common Stock 1,822 $11.31 $20,606.82
Disclosure

SEC source: 0001209191-23-014276 · doc4.xml · nonDerivative · entry 2

Davis Andrew · CIK 0001932525 · SVP, Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,396

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.26 to $11.38, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 18:21 UTC
Shetzline MichaelCMO,SVP,Head-Res&Drug
SaleClass A Common Stock 2,322 $11.41 $26,494.02
Disclosure

SEC source: 0001209191-23-014280 · doc4.xml · nonDerivative · entry 2

Shetzline Michael · CIK 0001808509 · CMO,SVP,Head-Res&Drug

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 271,440

F3 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based restricted stock units granted on February 27, 2020 and April 24, 2020. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.29 to $11.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 18:21 UTC
Shetzline MichaelCMO,SVP,Head-Res&Drug
SaleClass A Common Stock 7,146 $11.41 $81,535.86
Disclosure

SEC source: 0001209191-23-014280 · doc4.xml · nonDerivative · entry 1

Shetzline Michael · CIK 0001808509 · CMO,SVP,Head-Res&Drug

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 273,762

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.29 to $11.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 18:19 UTC
John MinardoChief Legal Officer
SaleClass A Common Stock 3,282 $11.41 $37,447.62
Disclosure

SEC source: 0001209191-23-014277 · doc4.xml · nonDerivative · entry 1

John Minardo · CIK 0001875067 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,153

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.29 to $11.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 18:24 UTC
Rickard JasonSVP, Chief Operating Officer
SaleClass A Common Stock 3,308 $11.41 $37,744.28
Disclosure

SEC source: 0001209191-23-014285 · doc4.xml · nonDerivative · entry 2

Rickard Jason · CIK 0001808505 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 350,077

F3 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based restricted stock units granted on February 27, 2020. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.29 to $11.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 18:24 UTC
Rickard JasonSVP, Chief Operating Officer
SaleClass A Common Stock 13,438 $11.41 $153,327.58
Disclosure

SEC source: 0001209191-23-014285 · doc4.xml · nonDerivative · entry 1

Rickard Jason · CIK 0001808505 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 353,385

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.29 to $11.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 18:22 UTC
MCCOURT Thomas ADirector · Chief Executive Officer
SaleClass A Common Stock 4,409 $11.41 $50,306.69
Disclosure

SEC source: 0001209191-23-014283 · doc4.xml · nonDerivative · entry 2

MCCOURT Thomas A · CIK 0001478448 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 712,581

F3 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based restricted stock units granted on February 27, 2020. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.29 to $11.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 18:22 UTC
MCCOURT Thomas ADirector · Chief Executive Officer
SaleClass A Common Stock 25,595 $11.41 $292,038.95
Disclosure

SEC source: 0001209191-23-014283 · doc4.xml · nonDerivative · entry 1

MCCOURT Thomas A · CIK 0001478448 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 716,990

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.29 to $11.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 23:25 UTC
Silver RonaldPrincipal Accounting Officer
SaleClass A Common Stock 2,929 $11.41 $33,419.89
Disclosure

SEC source: 0001209191-23-014286 · doc4.xml · nonDerivative · entry 1

Silver Ronald · CIK 0001873731 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,540

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.29 to $11.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 23:17 UTC
Davis AndrewSVP, Chief Business Officer
SaleClass A Common Stock 1,751 $11.41 $19,978.91
Disclosure

SEC source: 0001209191-23-014276 · doc4.xml · nonDerivative · entry 1

Davis Andrew · CIK 0001932525 · SVP, Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,218

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.29 to $11.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · balance_after: The reporting person acquired 756 shares of Class A Common Stock under the issuer's employee stock purchase plan on December 31, 2022.

Read SEC document
January 17, 2023 Filed Jan 19, 2023 16:05 UTC
Shetzline MichaelCMO,SVP,Head-Res&Drug
GrantClass A Common Stock 14,663 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-003999 · doc4.xml · nonDerivative · entry 1

Shetzline Michael · CIK 0001808509 · CMO,SVP,Head-Res&Drug

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 280,908

F1 · kind: Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted February 27, 2020 and April 24, 2020. The earned PSUs were certified and vested on January 17, 2023.

Read SEC document
January 17, 2023 Filed Jan 19, 2023 16:05 UTC
Rickard JasonSVP, Chief Operating Officer
GrantClass A Common Stock 18,087 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-003991 · doc4.xml · nonDerivative · entry 1

Rickard Jason · CIK 0001808505 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 366,823

F1 · kind: Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted February 27, 2020. The earned PSUs were certified and vested on January 17, 2023.

Read SEC document
January 17, 2023 Filed Jan 19, 2023 16:05 UTC
MCCOURT Thomas ADirector · Chief Executive Officer
GrantClass A Common Stock 30,145 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-003990 · doc4.xml · nonDerivative · entry 1

MCCOURT Thomas A · CIK 0001478448 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 742,585

F1 · kind: Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted February 27, 2020. The earned PSUs were certified and vested on January 17, 2023.

Read SEC document
January 05, 2023 Filed Jan 9, 2023 16:05 UTC
MCCOURT Thomas ADirector · Chief Executive Officer
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative 110,962 $0.00 Strike: $11.65 $0.00
Disclosure

SEC source: 0001209191-23-002543 · doc4.xml · derivative · entry 3

MCCOURT Thomas A · CIK 0001478448 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 110,962 shares

Expires 2023-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The options, vested as to 1.25% on each monthly anniversary of the vesting commencement date for the first 36 months, and as to 4.5833% of the award on each monthly anniversary thereafter, are presently exercisable in full.

Read SEC document
January 05, 2023 Filed Jan 9, 2023 16:05 UTC
MCCOURT Thomas ADirector · Chief Executive Officer
SaleClass A Common Stock 110,962 $12.07 $1,339,311.34
Disclosure

SEC source: 0001209191-23-002543 · doc4.xml · nonDerivative · entry 2

MCCOURT Thomas A · CIK 0001478448 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 712,440

F1 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.01 to $12.29, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
January 05, 2023 Filed Jan 9, 2023 16:05 UTC
MCCOURT Thomas ADirector · Chief Executive Officer
Exercise / conversionClass A Common Stock 110,962 $11.65 $1,292,707.30
Disclosure

SEC source: 0001209191-23-002543 · doc4.xml · nonDerivative · entry 1

MCCOURT Thomas A · CIK 0001478448 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 823,402

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 21:14 UTC
DENNER ALEXANDER JDirector · 10% owner
GrantClass A Common Stock 1,244 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-061864 · doc4.xml · nonDerivative · entry 1

DENNER ALEXANDER J · CIK 0001361754 · Director · 10% owner

Sarissa Capital Management LP · CIK 0001577524 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,985

F1 · kind: Issued pursuant to the Director Compensation Policy, effective May 2019.

Read SEC document
December 14, 2022 Filed Dec 16, 2022 16:05 UTC
Rickard JasonSVP, Chief Operating Officer
SaleClass A Common Stock 27,000 $12.39 $334,530.00
Disclosure

SEC source: 0001209191-22-061644 · doc4.xml · nonDerivative · entry 1

Rickard Jason · CIK 0001808505 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 348,736

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.38 to $12.41,inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
November 21, 2022 Filed Nov 23, 2022 21:05 UTC
Emany Sravan KumarSVP, Chief Financial Officer
SaleClass A Common Stock 6,578 $11.56 $76,041.68
Disclosure

SEC source: 0001209191-22-058611 · doc4.xml · nonDerivative · entry 1

Emany Sravan Kumar · CIK 0001897662 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,422

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
November 21, 2022 Filed Nov 23, 2022 21:05 UTC
Silver RonaldPrincipal Accounting Officer
SaleClass A Common Stock 682 $11.56 $7,883.92
Disclosure

SEC source: 0001209191-22-058612 · doc4.xml · nonDerivative · entry 1

Silver Ronald · CIK 0001873731 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,469

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
November 21, 2022 Filed Nov 23, 2022 21:05 UTC
Davis AndrewSVP, Chief Business Officer
SaleClass A Common Stock 3,335 $11.56 $38,552.60
Disclosure

SEC source: 0001209191-22-058607 · doc4.xml · nonDerivative · entry 1

Davis Andrew · CIK 0001932525 · SVP, Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,213

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · balance_after: The reporting person acquired 1,032 shares of Class A Common Stock under the issuer's employee stock purchase plan on June 30, 2022.

Read SEC document
October 03, 2022 Filed Oct 5, 2022 16:05 UTC
MCCOURT Thomas ADirector · Chief Executive Officer
SaleClass A Common Stock 18,899 $10.41 $196,738.59
Disclosure

SEC source: 0001209191-22-052718 · doc4.xml · nonDerivative · entry 1

MCCOURT Thomas A · CIK 0001478448 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 712,440

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.25 to $10.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
September 15, 2022 Filed Sep 19, 2022 20:05 UTC
DENNER ALEXANDER JDirector · 10% owner
GrantClass A Common Stock 1,374 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-050483 · doc4.xml · nonDerivative · entry 1

DENNER ALEXANDER J · CIK 0001361754 · Director · 10% owner

Sarissa Capital Management LP · CIK 0001577524 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,741

F1 · kind: Issued pursuant to the Director Compensation Policy, effective May 2019.

Read SEC document
September 01, 2022 Filed Sep 6, 2022 16:05 UTC
MCCOURT Thomas ADirector · Chief Executive Officer
SaleClass A Common Stock 26,446 $10.65 $281,649.90
Disclosure

SEC source: 0001209191-22-048716 · doc4.xml · nonDerivative · entry 1

MCCOURT Thomas A · CIK 0001478448 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 731,339

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.59 to $10.72, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
August 15, 2022 Filed Aug 17, 2022 16:05 UTC
John MinardoChief Legal Officer
SaleClass A Common Stock 7,330 $11.77 $86,274.10
Disclosure

SEC source: 0001209191-22-046220 · doc4.xml · nonDerivative · entry 1

John Minardo · CIK 0001875067 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,435

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.